Mechanism of 2‐chloroadenosine toxicity to PC3 cell line

2‐CADO inhibits the growth of several types of cells and causes apoptosis by a mechanism which involves adenosine receptors or cellular uptake or both.

[1]  C. Elford,et al.  Human Osteoblast Precursors Produce Extracellular Adenosine, Which Modulates Their Secretion of IL‐6 and Osteoprotegerin , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  M. Agostini,et al.  Cytostatic Effect of the Nucleoside Analogue 2-Chloroadenosine on Human Prostate Cancer Cell Line , 2005 .

[3]  B. Fredholm,et al.  Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor. , 2005, Biochemical pharmacology.

[4]  G. Bartsch,et al.  Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours. , 2005, Endocrine-related cancer.

[5]  P. Smolewski,et al.  In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells , 2005, European journal of haematology.

[6]  P. Johnston,et al.  Molecular mechanisms of drug resistance , 2005, The Journal of pathology.

[7]  I. Biaggioni,et al.  Adenosine-Activated Mast Cells Induce IgE Synthesis by B Lymphocytes: An A2B-Mediated Process Involving Th2 Cytokines IL-4 and IL-13 with Implications for Asthma12 , 2004, The Journal of Immunology.

[8]  T. Nishizaki,et al.  Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. , 2004, Biochemical pharmacology.

[9]  Daniel J Schaid,et al.  The complex genetic epidemiology of prostate cancer. , 2004, Human molecular genetics.

[10]  G. Sancesario,et al.  2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines. , 2004, Biochemical pharmacology.

[11]  K. Jacobson,et al.  Role of direct RhoA‐phospholipase D interaction in mediating adenosine‐induced protection from cardiac ischemia , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  K. Jacobson,et al.  Adenosine-induced cell death: evidence for receptor-mediated signalling , 1999, Apoptosis.

[13]  Z. Kiliańska,et al.  2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo. , 2004, Cancer detection and prevention.

[14]  W. Plunkett,et al.  Mechanisms of apoptosis induction by nucleoside analogs , 2003, Oncogene.

[15]  Nai-Kuei Huang,et al.  Adenosine A2A receptors regulate oxidative stress formation in rat pheochromocytoma PC12 cells during serum deprivation , 2003, Neuroscience Letters.

[16]  M. Scanlon,et al.  Adenosine‐induced IL‐6 expression in pituitary folliculostellate cells is mediated via A2b adenosine receptors coupled to PKC and p38 MAPK , 2003, British journal of pharmacology.

[17]  P. Reichard.  Ribonucleotide reductases: the evolution of allosteric regulation. , 2002, Archives of biochemistry and biophysics.

[18]  U. Uhlin,et al.  Structure and function of the radical enzyme ribonucleotide reductase. , 2001, Progress in biophysics and molecular biology.

[19]  C. Smal,et al.  Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  Sang Gyun Kim,et al.  8‐Cl‐cAMP induces cell cycle‐specific apoptosis in human cancer cells , 2001, International journal of cancer.

[21]  H. Wilms,et al.  ATP and adenosine induce ramification of microglia in vitro , 2001, Journal of Neuroimmunology.

[22]  A. IJzerman,et al.  Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake. , 2001, Biochemical pharmacology.

[23]  W. Plunkett,et al.  S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine. , 2001, Cancer research.

[24]  J. T. Corwin,et al.  Brief Treatments with Forskolin Enhance S-Phase Entry in Balance Epithelia from the Ears of Rats , 2001, The Journal of Neuroscience.

[25]  P. Fishman,et al.  Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor , 2001, Journal of cellular physiology.

[26]  J. Stubbe.  Ribonucleotide reductases: the link between an RNA and a DNA world? , 2000, Current opinion in structural biology.

[27]  F. Bontemps,et al.  Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2'-deoxyadenosine. , 2000, Biochemical pharmacology.

[28]  F. Cattabeni,et al.  Apoptosis induced by 2‐chloro‐adenosine and 2‐chloro‐2′‐deoxy‐adenosine in a human astrocytoma cell line: Differential mechanisms and possible clinical relevance , 2000, Journal of neuroscience research.

[29]  T. McDonnell,et al.  TabBO: a model reflecting common molecular features of androgen-independent prostate cancer. , 2000, Clinical Cancer Research.

[30]  G. Chrousos,et al.  Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes , 2000, The Journal of Immunology.

[31]  A. Felipe,et al.  Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies. , 1998, Trends in pharmacological sciences.

[32]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[33]  S. Aykol,et al.  The effects of 2-chloroadenosine and deoxycoformycin on the ATP level, Na-K ATPase activity in experimental brain ischemia of gerbil. , 1996, Neurological research.

[34]  H. Klocker,et al.  Regulation of prostatic growth and function by peptide growth factors , 1996, The Prostate.

[35]  C. Perno,et al.  An ion-pairing high-performance liquid chromatographic method for the direct simultaneous determination of nucleotides, deoxynucleotides, nicotinic coenzymes, oxypurines, nucleosides, and bases in perchloric acid cell extracts. , 1995, Analytical biochemistry.

[36]  W. Plunkett,et al.  Induction of apoptosis by gemcitabine. , 1995, Seminars in oncology.

[37]  J. Houghton,et al.  Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  J. Cidlowski,et al.  Cell cycle and apoptosis: Common pathways to life and death , 1995, Journal of cellular biochemistry.

[39]  M. Colombel,et al.  Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. , 1992, Cancer research.

[40]  S. Claeyssens,et al.  Influence of 2‐chloroadenosine on the nucleotide content of isolated rat hepatocytes , 1988, FEBS letters.

[41]  H. Yamanaka,et al.  2-Chloroadenosine is phosphorylated and increases the production of hypoxanthine in human cells. , 1986, Advances in experimental medicine and biology.

[42]  D. Carson,et al.  Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. , 1985, The Journal of clinical investigation.

[43]  H. Yamanaka,et al.  Relationship between phosphorylation and cytotoxicity of 2-chloroadenosine and 6-methylmercaptopurine riboside in human cells. , 1984, Biochimica et biophysica acta.